Bharat Biotech’s COVID-19 vaccine, Covaxin, has been recommended for emergency use approval to the DCGI by the expert panel.
If approved by the drugs regulator, Covaxin will become the second vaccine, after Zydus Cadila’s ZyCoV-D, to be approved for inoculating children in the country.